Alveolo-interstitial pneumonia due to Temozolamide;Pneumonie alvéolo-interstitielle au témozolomide

Revue des Maladies Respiratoires

Volumn 25, Issue 7, 2008, Pages 880-884

  Guilleminault, L ^a,b   Carre P ^a   De Luca, K ^a   Beau Salinas, F ^a   Autret Leca, E ^a   Narciso, B ^a   Diot, P ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

Alveolo interstitial pneumonia; Drug induced pneumonia; Hypersensitivity pneumonia; Organising pneumonia; Temozolomide

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; METHYLPREDNISOLONE; TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; FEMALE; GLIOBLASTOMA; HUMAN; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS; LUNG LAVAGE; LYMPHOCYTOSIS;

EID: 55049089289     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(08)74357-2     Document Type: Article

References (6)

1. Maldonado F, Limper AH, Lim KG, Aubry MC: Temozolomide-associated organizing pneumonitis. Mayo Clinic Proceedings 2007; 82: 771-3.
2. Abrey LE, Olson JD, Raizer JJ, Mack M, Rodavitch A, Boutros DY, Malkin MGA: Phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J Neurooncol 2001; 53: 259-65.
3. Yu SK, Chalmers AJ: Patients Receiving Standard-dose Temozolomide Therapy are at Risk of Pneumocystis carinii Pneumonia. Clin Oncol (R Coll Radiol) 2007; 19: 631-2.
4. Schwarzberg AB, Stover EH, Sengupta T, Michelini A, Vincitore M, Baden LR, Kulke MH: Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. Cancer Invest 2007; 25: 249-55.
5. Begaud B, Evreux JC, Jarglard J, Lagier G: Imputabilité des effets inattendus ou toxiques des médicaments. Thérapie 1985; 40: 111-8.
6. Cordier JF: Cryptogenic organising pneumonia. Eur Respir J 2006; 28: 422-46.